United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 171,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "8b70e275-0ac5-4b26-aa52-0efbe18c0b8b",
"title": "В США пытаются регулировать цены на лекарства: почти как в Беларуси",
"description": "12 мая президент Трамп подписал указ, согласно которому фармкомпании обязаны в 30-дневный срок снизить цены на рецептурные препараты в США. Министерству здравоохранения и социальных служб США предписано в течение месяца определить ценовые ориентиры для производителей, которым дается 6 месяцев, чтобы привести цены в соответствие с установленными значениями. В противном случае власти грозят применить административные меры по удешевлению лекарств и отменить торговые ограничения для импорта.",
"keywords": "лекарства, какое лекарство, лекарства можно, официальный лекарства, наличие лекарств и цены, бесплатные лекарства, сколько лекарство, цена лекарств",
"snippet": "Изображение носит иллюстративный характер. Фото из открытых источников\n\nИзображение н?...",
"url": "https://myfin.by/article/biznes/v-ssa-pytautsa-regulirovat-ceny-na-lekarstva-pocti-kak-v-belarusi-37565",
"image_url": "https://myfin.by/source//1/kfqNvL-sqfDWiO_Kg9WBRWBx4kApb7bl.jpeg",
"language": "ru",
"published_at": "2025-05-18T13:10:00.000000Z",
"source": "myfin.by",
"relevance_score": null,
"entities": [
{
"symbol": "JNJ",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.173904,
"sentiment_score": null,
"highlights": [
{
"highlight": ".) — на 6%, Pfizer, Amgen и Bristol[+314 characters]",
"sentiment": 0.6908,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "28eb8f02-330e-4598-bf00-6d0be79ea4d7",
"title": "Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peri",
"description": "Intellia Therapeutics (NTLA) showcased a 90% reduction in serum TTR maintained for 24 months in the Phase 1 study of nexiguran ziclumeran (nex-z). 14 ou",
"keywords": "GuruFocus, Article, News, GuruFocus News, NTLA",
"snippet": "Intellia Therapeutics (NTLA, Financial) showcased a 90% reduction in serum TTR maintained for 24 months in the Phase 1 study of nexiguran ziclumeran (nex-z).\n\n1...",
"url": "https://www.gurufocus.com/news/2872125/intellia-announces-positive-twoyear-followup-data-from-ongoing-phase-1-study-of-nexiguran-ziclumeran-nexz-in-patients-with-hereditary-transthyretin-attr-amyloidosis-with-polyneuropathy-at-peri",
"image_url": "https://static.gurufocus.com/logos/0C0000B3JR.png?20",
"language": "en",
"published_at": "2025-05-18T12:45:16.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "NTLA",
"name": "Intellia Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 50.540073,
"sentiment_score": 0.58765,
"highlights": [
{
"highlight": "<em>Intellia</em> <em>Therapeutics</em> [+233 characters]",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Intellia</em> <em>Therapeutics</em>,[+224 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "8f92506a-8654-46bd-af56-09b0f3dfa274",
"title": "Hanover Insurance: Initiating A Buy Following Strong Q1 Results (NYSE:THG)",
"description": "The Hanover Insurance Group posted strong Q1 results and a solid growth outlook, with a fair valuation. Learn why THG stock is a buy.",
"keywords": "",
"snippet": "The Hanover Insurance Group ( THG ) is a company that traces its roots back to 1852. That is something not many companies can say, and speaks to the durability ...",
"url": "https://seekingalpha.com/article/4787890-hanover-insurance-initiating-a-buy-following-strong-q1-results",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2191983529/image_2191983529.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-18T12:45:00.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "THG",
"name": "The Hanover Insurance Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 64.13689,
"sentiment_score": 0.2553,
"highlights": [
{
"highlight": "<em>The</em> <em>Hanover</em> <em>Insura[+169 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Hanover Insurance: Initiating A Buy Following Strong Q1 Results (<em>NYSE:THG</em>)",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "2f5ab949-8ba2-424e-996b-de72e99f1e7d",
"title": "JEPI: Highest Dividend Since December 2022, Battle-Tested",
"description": "Discover why JEPI is a strong buy for income investors. Yielding 8%, it offers resilience, low volatility, and diversified large-cap exposure.",
"keywords": "",
"snippet": "The market has dealt with its share of blows in the last five-plus years. Indeed, US large caps are now very battle-tested. Amid it all, the JPMorgan Equity Pre...",
"url": "https://seekingalpha.com/article/4787945-jepi-highest-dividend-since-december-2022-battle-tested",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2187254257/image_2187254257.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-18T12:30:25.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "JEPI",
"name": "JPMorgan Equity Premium Income ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 83.925705,
"sentiment_score": 0.5106,
"highlights": [
{
"highlight": "Amid it all, the <em>JPMorgan</em> <em>E[+376 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^JEPI-NV",
"name": "JPMORGAN EQUITY PREMIUM INCOME ",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 40.75925,
"sentiment_score": 0.5106,
"highlights": [
{
"highlight": "Amid it all, the <em>JPMorgan</em> <em>E[+349 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^JEPI-TC",
"name": "JPMORGAN EQUITY PREMIUM INCOME ",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 40.75925,
"sentiment_score": 0.5106,
"highlights": [
{
"highlight": "Amid it all, the <em>JPMorgan</em> <em>E[+349 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^JEPI-EU",
"name": "JPMORGAN EQUITY PREMIUM INCOME ",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 40.75925,
"sentiment_score": 0.5106,
"highlights": [
{
"highlight": "Amid it all, the <em>JPMorgan</em> <em>E[+349 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "06546ded-c7ca-4140-9f74-437b8f5e6eb3",
"title": "TC Energy: Sleep Well At Night Income (NYSE:TRP)",
"description": "TC Energy offers stable income through fee-based revenues, strong gas assets, and a 4.9% yield, but trades above historical value. Find out why TRP stock is a hold.",
"keywords": "",
"snippet": "iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity f...",
"url": "https://seekingalpha.com/article/4787882-tc-energy-sleep-well-at-night-income",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1990350877/image_1990350877.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-18T12:30:00.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "TRP",
"name": "TC Energy Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 98.44736,
"sentiment_score": 0.2732,
"highlights": [
{
"highlight": "<em>TC</em> <em>Energy</em>: Sleep Well At Night Income (<em>NYSE:TRP</em>)",
"sentiment": 0.2732,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "899374db-dc0d-46fc-8815-0f5059329ba7",
"title": "Clearway Energy Stock: A Strong Vehicle For Income And Growth (NYSE:CWEN.A)",
"description": "Clearway Energy's Q1 2025 results were robust, with CAFD up nearly 50% year-over-year. Read why CWEN.A stock is a top choice for income investors.",
"keywords": "",
"snippet": "Clearway Energy (NYSE: CWEN.A )(NYSE: CWEN ) has been a quiet outperformer this year vs. the broader US stock market. Recently, the company reported strong Q1 r...",
"url": "https://seekingalpha.com/article/4787917-clearway-energy-a-strong-vehicle-for-income-and-growth",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1781790467/image_1781790467.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-18T09:40:14.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "CWEN",
"name": "Clearway Energy, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Utilities",
"match_score": 81.29288,
"sentiment_score": 0.6881,
"highlights": [
{
"highlight": "<em>Clearway</em> <em>Energy</em> (NYSE:[+343 characters]",
"sentiment": 0.6666,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Clearway</em> <em>Energy</em> Stock: A Strong Vehicle For Income And Growth (NYSE:CWEN.A)",
"sentiment": 0.7096,
"highlighted_in": "title"
}
]
},
{
"symbol": "CWEN-A",
"name": "Clearway Energy, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Utilities",
"match_score": 64.07829,
"sentiment_score": 0.6881,
"highlights": [
{
"highlight": "<em>Clearway</em> <em>Energy</em> (NYSE:[+325 characters]",
"sentiment": 0.6666,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Clearway</em> <em>Energy</em> Stock: A Strong Vehicle For Income And Growth (NYSE:CWEN.A)",
"sentiment": 0.7096,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "8738dacc-90e1-4d43-a746-a99900b2c8a7",
"title": "MakeMyTrip Stock: Growth Runway Still Visible And Clear (NASDAQ:MMYT)",
"description": "MakeMyTrip delivered strong 4Q25 results, driven by 30%+ bookings growth, AI innovation, and expanding international revenue. See why MMYT stock is a buy.",
"keywords": "",
"snippet": "I wrote about MakeMyTrip Ltd. ( MMYT ) previously with a buy rating, as the 3Q25 results were very supportive of my bullish view, in that MMYT continues to be t...",
"url": "https://seekingalpha.com/article/4787937-makemytrip-growth-runway-still-visible-and-clear",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2028402518/image_2028402518.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-18T12:22:31.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "MMYT",
"name": "MakeMyTrip Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 86.69825,
"sentiment_score": 0.64065,
"highlights": [
{
"highlight": "I wrote about <em>MakeMyTrip</em> Ltd. ([+266 characters]",
"sentiment": 0.6444,
"highlighted_in": "main_text"
},
{
"highlight": "<em>MakeMyTrip</em> Stock: Growth Runway Still Visible And Clear (<em>NASDAQ:MMYT</em>)",
"sentiment": 0.6369,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "07a5b05b-f874-47a7-b18d-df4b5546a1e5",
"title": "Class Action Filed Against Napco Security Technologies, Inc. (NSSC) Over Securities Violations - Contact Levi & Korsinsky Today",
"description": "NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Napco Security Technologies, Inc. (NASDAQ:NSSC) investment and want...",
"keywords": "",
"snippet": "NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Napco Security Technologies, Inc. (NASDAQ:NSSC) investment and want to learn abou...",
"url": "https://markets.businessinsider.com/news/stocks/class-action-filed-against-napco-security-technologies-inc-nssc-over-securities-violations---contact-levi-korsinsky-today-1034740166",
"image_url": "https://app.accessnewswire.com/img.ashx?id=1029024",
"language": "en",
"published_at": "2025-05-18T12:17:00.000000Z",
"source": "markets.businessinsider.com",
"relevance_score": null,
"entities": [
{
"symbol": "NSSC",
"name": "Napco Security Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 162.13579,
"sentiment_score": -0.5667,
"highlights": [
{
"highlight": "NEW YORK, NY / ACCESS Newswire / May 18,[+386 characters]",
"sentiment": -0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "THE LAWSUIT: A class action securities l[+242 characters]",
"sentiment": -0.8415,
"highlighted_in": "main_text"
},
{
"highlight": "If you suffered a loss in Napco stock du[+320 characters]",
"sentiment": -0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Class Action Filed Against <em>Napco</em> <em>Security</em> <em>Technologies</em>, <em>Inc</em>. (NSSC) Over Securities Violations - Contact Levi & Korsinsky Today",
"sentiment": -0.296,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "eb7c6778-e34e-4863-97a0-76ebe4966d0f",
"title": "Class Action Alert: Levi & Korsinsky Reminds Viatris (VTRS) Investors of June 3, 2025 Deadline",
"description": "NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a pot...",
"keywords": "",
"snippet": "NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recover...",
"url": "https://markets.businessinsider.com/news/stocks/class-action-alert-levi-korsinsky-reminds-viatris-vtrs-investors-of-june-3-2025-deadline-1034740163",
"image_url": "https://app.accessnewswire.com/img.ashx?id=1029020",
"language": "en",
"published_at": "2025-05-18T12:17:00.000000Z",
"source": "markets.businessinsider.com",
"relevance_score": null,
"entities": [
{
"symbol": "VTRSV",
"name": "Viatris Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 54.683235,
"sentiment_score": -0.373343,
"highlights": [
{
"highlight": "NEW YORK, NY / ACCESS Newswire / May 18,[+300 characters]",
"sentiment": -0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "THE LAWSUIT: A class action securities l[+202 characters]",
"sentiment": -0.8415,
"highlighted_in": "main_text"
},
{
"highlight": "CASE DETAILS: According to the complaint[+260 characters]",
"sentiment": -0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "On February 27, 2025, <em>Viatris</em> a[+267 characters]",
"sentiment": -0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "Following this news, the price of <em>Vi[+267 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "If you suffered a loss in <em>Viatris</e[+293 characters]",
"sentiment": -0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Class Action Alert: Levi & Korsinsky Reminds <em>Viatris</em> (VTRS) Investors of June 3, 2025 Deadline",
"sentiment": 0.296,
"highlighted_in": "title"
}
]
},
{
"symbol": "VTRS",
"name": "Viatris Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 67.01104,
"sentiment_score": -0.373343,
"highlights": [
{
"highlight": "NEW YORK, NY / ACCESS Newswire / May 18,[+309 characters]",
"sentiment": -0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "THE LAWSUIT: A class action securities l[+202 characters]",
"sentiment": -0.8415,
"highlighted_in": "main_text"
},
{
"highlight": "CASE DETAILS: According to the complaint[+260 characters]",
"sentiment": -0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "On February 27, 2025, <em>Viatris</em> a[+267 characters]",
"sentiment": -0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "Following this news, the price of <em>Vi[+267 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "If you suffered a loss in <em>Viatris</e[+293 characters]",
"sentiment": -0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Class Action Alert: Levi & Korsinsky Reminds <em>Viatris</em> (VTRS) Investors of June 3, 2025 Deadline",
"sentiment": 0.296,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "34f51e45-145e-40b8-bc9f-f7352fc81d07",
"title": "Investors in Sana Biotechnology, Inc. (SANA): Protect Your Rights - Contact Levi & Korsinsky Before May 20, 2025",
"description": "NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to learn...",
"keywords": "",
"snippet": "NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to learn about a poten...",
"url": "https://markets.businessinsider.com/news/stocks/investors-in-sana-biotechnology-inc-sana-protect-your-rights---contact-levi-korsinsky-before-may-20-2025-1034740165",
"image_url": "https://app.accessnewswire.com/img.ashx?id=1029023",
"language": "en",
"published_at": "2025-05-18T12:17:00.000000Z",
"source": "markets.businessinsider.com",
"relevance_score": null,
"entities": [
{
"symbol": "SANA",
"name": "Sana Biotechnology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 131.31776,
"sentiment_score": -0.39725,
"highlights": [
{
"highlight": "NEW YORK, NY / ACCESS Newswire / May 18,[+348 characters]",
"sentiment": -0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "THE LAWSUIT: A class action securities l[+222 characters]",
"sentiment": -0.8415,
"highlighted_in": "main_text"
},
{
"highlight": "If you suffered a loss in <em>Sana</em> [+346 characters]",
"sentiment": -0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Investors in <em>Sana</em> <em>Biotechnology</em>, <em>Inc</em>. (SANA): Protect Your Rights - Contact Levi & Korsinsky Before May 20, 2025",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "ce20cc0e-0a03-41d6-a1ed-d33dbe7575a4",
"title": "Investor Alert: Deadline Approaching to Join Compass Group Diversified Holdings, LLC (CODI) Class Action - Contact Levi & Korsinsky",
"description": "NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and ...",
"keywords": "",
"snippet": "NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn ...",
"url": "https://markets.businessinsider.com/news/stocks/investor-alert-deadline-approaching-to-join-compass-group-diversified-holdings-llc-codi-class-action---contact-levi-korsinsky-1034740162",
"image_url": "https://app.accessnewswire.com/img.ashx?id=1029019",
"language": "en",
"published_at": "2025-05-18T12:17:00.000000Z",
"source": "markets.businessinsider.com",
"relevance_score": null,
"entities": [
{
"symbol": "CODI",
"name": "Compass Diversified",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 65.35985,
"sentiment_score": -0.56465,
"highlights": [
{
"highlight": "NEW YORK, NY / ACCESS Newswire / May 18,[+322 characters]",
"sentiment": -0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "If you suffered a loss in <em>Compass</e[+320 characters]",
"sentiment": -0.6705,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 286,
"sentiment_avg": 0.3283897226351793
}
]
}
Other details
Entity count
- 32,649